Croessmann, Sarah
Wong, Hong Yuen
Zabransky, Daniel J.
Chu, David
Rosen, D. Marc
Cidado, Justin
Cochran, Rory L.
Dalton, W. Brian
Erlanger, Bracha
Cravero, Karen
Button, Berry
Kyker-Snowman, Kelly
Hurley, Paula J.
Lauring, Josh
Park, Ben Ho
Funding for this research was provided by:
Avon Foundation for Women
National Cancer Institute (CA009071, CA009071, CA168180, CA167939)
National Institute of General Medical Sciences (GM007309)
Breast Cancer Research Foundation
Article History
Received: 1 February 2017
Accepted: 6 February 2017
First Online: 11 February 2017
Compliance with ethical standards
:
: BHP is a paid member of the scientific advisory boards of Horizon Discovery, LTD, and Loxo Oncology, and has research contracts with Genomic Health, Inc and Foundation Medicine, Inc. Under separate licensing agreements between Horizon Discovery, LTD, and The Johns Hopkins University, BHP is entitled to a share of royalties received by the University on sales of products. The terms of this arrangement are being managed by the Johns Hopkins University, in accordance with its conflict of interest policies. All other authors declare no potential conflicts.
: All animal experiments were performed in accordance with institutional and the National Institutes of Health Guide for the Care and Use of Laboratory Animals guidelines. This article does not contain any studies with human participants performed by any of the authors.